David Altshuler, Vertex Pharmaceuticals (VRTX)’s insider Sold 56,250 Shares; 12 Bullish Analysts Covering Fortune Brands Home & Security, Inc. (FBHS)

Among 18 analysts covering Fortune Brands Home & Security (NYSE:FBHS), 12 have Buy rating, 0 Sell and 6 Hold. Therefore 67% are positive. Fortune Brands Home & Security had 48 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets on Thursday, October 27 with “Outperform”. The stock of Fortune Brands Home & Security, Inc. (NYSE:FBHS) earned “Outperform” rating by Robert W. Baird on Thursday, April 21. The stock has “Buy” rating by Topeka Capital Markets on Tuesday, May 24. The firm has “Hold” rating by Wells Fargo given on Wednesday, July 19. The firm has “Buy” rating given on Monday, September 25 by RBC Capital Markets. The company was initiated on Friday, September 23 by Bank of America. The company was maintained on Tuesday, October 24 by KeyBanc Capital Markets. As per Monday, December 12, the company rating was downgraded by Goldman Sachs. RBC Capital Markets maintained the shares of FBHS in report on Sunday, August 20 with “Buy” rating. RBC Capital Markets maintained Fortune Brands Home & Security, Inc. (NYSE:FBHS) rating on Monday, November 13. RBC Capital Markets has “Buy” rating and $74.0 target. See Fortune Brands Home & Security, Inc. (NYSE:FBHS) latest ratings:

13/11/2017 Broker: RBC Capital Markets Rating: Buy New Target: $74.0 Maintain
30/10/2017 Broker: JP Morgan Rating: Overweight Old Target: $70 New Target: $78 Maintain
27/10/2017 Broker: Citigroup Rating: Neutral Old Target: $68 New Target: $71 Maintain
26/10/2017 Broker: Credit Suisse Rating: Outperform Old Target: $72 New Target: $74 Maintain
24/10/2017 Broker: KeyBanc Capital Markets Rating: Hold Maintain
24/10/2017 Broker: Robert W. Baird Rating: Buy New Target: $72.0 Maintain
11/10/2017 Broker: Jefferies Rating: Buy New Target: $78.0 Maintain
25/09/2017 Broker: RBC Capital Markets Rating: Buy New Target: $75.0 Maintain
19/09/2017 Broker: KeyBanc Capital Markets Rating: Hold Maintain
19/09/2017 Broker: Robert W. Baird Rating: Buy New Target: $72.0 Maintain

David Altshuler, an insider and also EVP – Global Research and CSO of the leading company Vertex Pharmaceuticals Inc Ma made a huge deal, which can’t stay a secret. He made a sale of 56,250 shares of the corporation with the insider transaction having a market value of $8,830,755 U.S. Dollars – based on an average price of $157.0 per every share. Published 17/01/2018, you can learn more about the trade by looking at the following public 4F filing here. The chance of this stocks unloading staying disregarded is little as it’s sizable one, with the EVP – Global Research and CSO now having ownership of 49,761 shares — that is 0.02% of the company’s market cap.

Vertex Pharmaceuticals Incorporated discovers, develops, makes, and commercializes medicines for serious diseases. The company has market cap of $39.70 billion. The firm focuses on developing and commercializing therapies for the treatment of cystic fibrosis and advancing its research and development programs. It has a 202.31 P/E ratio. It markets ORKAMBI (lumacaftor in combination with ivacaftor) for the treatment of patients with CF 12 years of age and older who have two copies (homozygous) of the F508del mutation in their cystic fibrosis transmembrane conductance regulator (CFTR) gene; and KALYDECO (ivacaftor) for the treatment of patients with CF 2 years of age and older who have the G551D mutation or other specified mutations in their CFTR gene.

Analysts await Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) to report earnings on January, 24. They expect $0.28 earnings per share, up 115.38% or $0.15 from last year’s $0.13 per share. VRTX’s profit will be $70.81 million for 140.17 P/E if the $0.28 EPS becomes a reality. After $0.24 actual earnings per share reported by Vertex Pharmaceuticals Incorporated for the previous quarter, Wall Street now forecasts 16.67% EPS growth.

The stock increased 0.82% or $1.28 during the last trading session, reaching $156.99. About 1.22M shares traded. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has risen 45.69% since January 18, 2017 and is uptrending. It has outperformed by 28.99% the S&P500.

Among 28 analysts covering Vertex Pharmaceuticals (NASDAQ:VRTX), 24 have Buy rating, 0 Sell and 4 Hold. Therefore 86% are positive. Vertex Pharmaceuticals has $205.0 highest and $85.0 lowest target. $168.73’s average target is 7.48% above currents $156.99 stock price. Vertex Pharmaceuticals had 81 analyst reports since July 31, 2015 according to SRatingsIntel. Jefferies maintained the stock with “Buy” rating in Thursday, October 26 report. As per Tuesday, September 13, the company rating was initiated by Raymond James. As per Friday, October 20, the company rating was maintained by BMO Capital Markets. The stock of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has “Buy” rating given on Monday, September 28 by Argus Research. The rating was downgraded by Barclays Capital on Tuesday, November 29 to “Equal-Weight”. On Tuesday, August 1 the stock rating was maintained by Cowen & Co with “Buy”. On Sunday, August 20 the stock rating was maintained by Jefferies with “Buy”. H.C. Wainwright upgraded the shares of VRTX in report on Friday, October 30 to “Buy” rating. The rating was maintained by Cowen & Co with “Hold” on Wednesday, July 5. BMO Capital Markets maintained it with “Buy” rating and $18000 target in Tuesday, July 18 report.

Since July 31, 2017, it had 0 insider purchases, and 24 selling transactions for $65.06 million activity. SMITH IAN F sold 2,125 shares worth $324,865. 1,796 shares valued at $287,360 were sold by ALTSHULER DAVID on Thursday, August 31. $521,198 worth of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) was sold by Chodakewitz Jeffrey. LEIDEN JEFFREY M sold $17.67M worth of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on Monday, December 11. 2,330 shares were sold by Parini Michael, worth $362,828 on Thursday, August 3. 4,250 shares valued at $675,750 were sold by Arbuckle Stuart A on Thursday, January 11. $131,571 worth of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) was sold by Silva Paul M on Monday, July 31.

Investors sentiment increased to 1.62 in Q3 2017. Its up 0.11, from 1.51 in 2017Q2. It increased, as 32 investors sold Vertex Pharmaceuticals Incorporated shares while 151 reduced holdings. 79 funds opened positions while 217 raised stakes. 231.42 million shares or 0.04% more from 231.33 million shares in 2017Q2 were reported. Rampart Investment Mngmt Ltd Liability Corporation has invested 0.18% of its portfolio in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). American Interest Gru Inc Inc holds 0.06% or 108,242 shares in its portfolio. Oppenheimer Asset Mgmt Inc reported 25,745 shares stake. Citigroup holds 138,351 shares. Van Eck Corporation has invested 0.16% of its portfolio in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Dynamic Cap Management Limited owns 0.44% invested in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) for 10,183 shares. Janney Montgomery Scott Limited Liability Corp invested 0.05% in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Btg Pactual Global Asset Ltd owns 4,389 shares for 0.21% of their portfolio. Nomura Asset Mgmt holds 31,800 shares. Ascend Cap Ltd Liability Corporation has 0.26% invested in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Clearbridge Investments Lc has 7.08 million shares. Andra Ap, Alabama-based fund reported 21,900 shares. Scotia Cap reported 16,801 shares. Etrade Cap Mngmt Limited has 9,303 shares. Quantbot Techs Ltd Partnership holds 0.02% or 1,506 shares.

Investors sentiment decreased to 0.98 in Q3 2017. Its down 0.13, from 1.11 in 2017Q2. It is negative, as 36 investors sold Fortune Brands Home & Security, Inc. shares while 143 reduced holdings. 48 funds opened positions while 127 raised stakes. 124.72 million shares or 6.35% less from 133.18 million shares in 2017Q2 were reported. Advantus Mngmt holds 0.03% or 15,394 shares. Nationwide Fund Advisors stated it has 0.08% of its portfolio in Fortune Brands Home & Security, Inc. (NYSE:FBHS). Greenwood Assocs Limited Liability Corp, a South Carolina-based fund reported 8,463 shares. Raymond James & Assocs accumulated 24,459 shares or 0% of the stock. Credit Suisse Ag, Switzerland-based fund reported 215,093 shares. Sandy Spring Natl Bank holds 0.17% of its portfolio in Fortune Brands Home & Security, Inc. (NYSE:FBHS) for 25,706 shares. Moreover, Blair William Il has 0.02% invested in Fortune Brands Home & Security, Inc. (NYSE:FBHS). Texas-based Motco has invested 0.02% in Fortune Brands Home & Security, Inc. (NYSE:FBHS). Loring Wolcott And Coolidge Fiduciary Advsr Llp Ma has invested 0% in Fortune Brands Home & Security, Inc. (NYSE:FBHS). Srb Corp reported 2,875 shares stake. Royal Bankshares Of Canada owns 229,454 shares for 0.01% of their portfolio. Qs Lc reported 3,028 shares stake. Hl Fincl Service Ltd Liability Corporation accumulated 6,127 shares. Weiss Multi owns 0.13% invested in Fortune Brands Home & Security, Inc. (NYSE:FBHS) for 51,061 shares. Finemark Bank And Tru invested 0.25% in Fortune Brands Home & Security, Inc. (NYSE:FBHS).

Fortune Brands Home & Security, Inc. provides home and security products for use in residential home repair, remodeling, new construction, and security applications. The company has market cap of $10.90 billion. It operates in four divisions: Cabinets, Plumbing, Doors, and Security. It has a 25.12 P/E ratio. The Cabinets segment makes custom, semi-custom, and stock cabinetry, as well as vanities for the kitchen, bath, and other parts of the home directly to kitchen and bath dealers, home centers, wholesalers, and builders in North America.

The stock increased 2.00% or $1.41 during the last trading session, reaching $71.81. About 1.39 million shares traded or 48.14% up from the average. Fortune Brands Home & Security, Inc. (NYSE:FBHS) has risen 11.70% since January 17, 2017 and is uptrending. It has underperformed by 5.00% the S&P500.

Since August 4, 2017, it had 0 insider buys, and 6 insider sales for $14.78 million activity. $5.71M worth of Fortune Brands Home & Security, Inc. (NYSE:FBHS) was sold by KLEIN CHRISTOPHER J on Friday, October 27. 5,000 shares valued at $357,500 were sold by WATERS RONALD V on Friday, January 5. 33,400 shares were sold by WYATT E LEE, worth $2.17M on Monday, September 18.